Gilead Sciences
Biopharmaceutical company that discovers, develops, manufactures and commercializes therapies for critical diseases. Learn more
Launch date
Employees
Market cap
€93.7b
Enterprise valuation
€109.3b (Public information from Sep 2024)
Share price
€68.88 GILD.MI
Foster City California (HQ)
No columns specified